Saiid Zarrabian's most recent trade in TuHURA Biosciences Inc. was a trade of 38,109 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Dec. 6, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TuHURA Biosciences Inc. | Saiid Zarrabian | Director, Head of Strategic Partnerships | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 06 Dec 2021 | 38,109 | 55,500 (0%) | 0% | 0.6 | 24,298 | Common Stock |
| TuHURA Biosciences Inc. | Saiid Zarrabian | Director, Head of Strategic Partnerships | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 06 Dec 2021 | 11,891 | 17,391 (0%) | 0% | 0.6 | 7,018 | Common Stock |
| TuHURA Biosciences Inc. | Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 2,715,004 | 2,715,004 | - | - | Options (Right to Buy) |